Literature DB >> 19017810

Eosinophil granules function extracellularly as receptor-mediated secretory organelles.

Josiane S Neves1, Sandra A C Perez, Lisa A Spencer, Rossana C N Melo, Lauren Reynolds, Ionita Ghiran, Salahaddin Mahmudi-Azer, Solomon O Odemuyiwa, Ann M Dvorak, Redwan Moqbel, Peter F Weller.   

Abstract

Intracellular granules in several types of leukocytes contain preformed proteins whose secretions contribute to immune and inflammatory functions of leukocytes, including eosinophils, cells notably associated with asthma, allergic inflammation, and helminthic infections. Cytokines and chemokines typically elicit extracellular secretion of granule proteins by engaging receptors expressed externally on the plasma membranes of cells, including eosinophils. Eosinophil granules, in addition to being intracellular organelles, are found as intact membrane-bound structures extracellularly in tissue sites of eosinophil-associated diseases. Neither the secretory capacities of cell-free eosinophil granules nor the presence of functional cytokine and chemokine receptors on membranes of leukocyte granules have been recognized. Here, we show that granules of human eosinophils express membrane receptors for a cytokine, IFN-gamma, and G protein-coupled membrane receptors for a chemokine, eotaxin, and that these receptors function by activating signal-transducing pathways within granules to elicit secretion from within granules. Capacities of intracellular granule organelles to function autonomously outside of eosinophils as independent, ligand-responsive, secretion-competent structures constitute a novel postcytolytic mechanism for regulated secretion of eosinophil granule proteins that may contribute to eosinophil-mediated inflammation and immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017810      PMCID: PMC2587599          DOI: 10.1073/pnas.0804547105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils.

Authors:  C Bandeira-Melo; K Sugiyama; L J Woods; P F Weller
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  Specific granules of human eosinophils have lysosomal characteristics: presence of lysosome-associated membrane proteins and acidification upon cellular activation.

Authors:  Terese Persson; Jero Calafat; Hans Janssen; Malgorzata Karawajczyk; Sven R Carlsson; Arne Egesten
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

3.  ATP-independent luminal oscillations and release of Ca2+ and H+ from mast cell secretory granules: implications for signal transduction.

Authors:  Ivan Quesada; Wei-Chun Chin; Pedro Verdugo
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

4.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

5.  Translocation of the tetraspanin CD63 in association with human eosinophil mediator release.

Authors:  Salahaddin Mahmudi-Azer; Gregory P Downey; Redwan Moqbel
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

6.  Cytolysis of eosinophils in nasal secretions.

Authors:  Kensuke Watanabe; Toshihiro Misu; Satomi Inoue; Hideo Edamatsu
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-02       Impact factor: 1.547

7.  Receptor internalization is required for eotaxin-induced responses in human eosinophils.

Authors:  Nives Zimmermann; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

Review 8.  The role of eosinophils in host defense against helminth parasites.

Authors:  Amy D Klion; Thomas B Nutman
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

9.  Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7.

Authors:  Nicodemus Tedla; Christianne Bandeira-Melo; Paolo Tassinari; David E Sloane; Mary Samplaski; David Cosman; Luis Borges; Peter F Weller; Jonathan P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-14       Impact factor: 11.205

10.  CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13.

Authors:  Kursteen S Price; Daniel S Friend; Elizabeth A Mellor; Nidia De Jesus; Gerald F M Watts; Joshua A Boyce
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04       Impact factor: 6.914

View more
  54 in total

Review 1.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 3.  Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.

Authors:  Shigeharu Ueki; Takahiro Tokunaga; Shigeharu Fujieda; Kohei Honda; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

4.  Reply to eosinophil cytolysis and release of cell-free granules.

Authors:  Helene F Rosenberg; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2013-12       Impact factor: 53.106

5.  Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes.

Authors:  Shigeharu Ueki; Yasunori Konno; Masahide Takeda; Yuki Moritoki; Makoto Hirokawa; Yoshinori Matsuwaki; Kohei Honda; Nobuo Ohta; Shiori Yamamoto; Yuri Takagi; Atsushi Wada; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2015-06-09       Impact factor: 10.793

Review 6.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

7.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Authors:  Elizabeth A Kelly; Stephane Esnault; Lin Ying Liu; Michael D Evans; Mats W Johansson; Sameer Mathur; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

Review 8.  Vesicular trafficking of immune mediators in human eosinophils revealed by immunoelectron microscopy.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Exp Cell Res       Date:  2016-08-22       Impact factor: 3.905

9.  Brefeldin A reduces tumor necrosis factor-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR, and NF-κB pathways in human keratinocytes.

Authors:  Yoon Jeong Nam; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-20       Impact factor: 3.000

10.  Expression and subcellular localization of the Qa-SNARE syntaxin17 in human eosinophils.

Authors:  Lívia A S Carmo; Felipe F Dias; Kássia K Malta; Kátia B Amaral; Revital Shamri; Peter F Weller; Rossana C N Melo
Journal:  Exp Cell Res       Date:  2015-08-06       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.